Results
|
521.
|
Impact of the extent of extraprostatic extension defined by Epstein's method in patients with negative surgical margins and negative lymph node invasion. [electronic resource] by
- Maubon, T
- Branger, N
- Bastide, C
- Lonjon, G
- Harvey-Bryan, K-A
- Validire, P
- Giusiano, S
- Rossi, D
- Cathelineau, X
- Rozet, F
Producer: 20170418
In:
Prostate cancer and prostatic diseases vol. 19
Availability: No items available.
|
|
522.
|
|
|
523.
|
|
|
524.
|
|
|
525.
|
SOCS1 inhibits migration and invasion of prostate cancer cells, attenuates tumor growth and modulates the tumor stroma. [electronic resource] by
- Villalobos-Hernandez, A
- Bobbala, D
- Kandhi, R
- Khan, M G M
- Mayhue, M
- Dubois, C M
- Ferbeyre, G
- Saucier, C
- Ramanathan, S
- Ilangumaran, S
Producer: 20180305
In:
Prostate cancer and prostatic diseases vol. 20
Availability: No items available.
|
|
526.
|
|
|
527.
|
|
|
528.
|
The concordance between the volume hotspot and the grade hotspot: a 3-D reconstructive model using the pathology outputs from the PROMIS trial. [electronic resource] by
- El-Shater Bosaily, A
- Valerio, M
- Hu, Y
- Freeman, A
- Jameson, C
- Brown, L
- Kaplan, R
- Hindley, R G
- Barratt, D
- Emberton, M
- Ahmed, H U
Publication details: Prostate cancer and prostatic diseases 09 2016
In:
Prostate cancer and prostatic diseases vol. 19
Availability: No items available.
|
|
529.
|
|
|
530.
|
|
|
531.
|
|
|
532.
|
A meta-analysis of cardiovascular events in intermittent androgen-deprivation therapy versus continuous androgen-deprivation therapy for prostate cancer patients. [electronic resource] by
- Jin, C
- Fan, Y
- Meng, Y
- Shen, C
- Wang, Y
- Hu, S
- Cui, C
- Xu, T
- Yu, W
- Jin, J
Producer: 20180125
In:
Prostate cancer and prostatic diseases vol. 19
Availability: No items available.
|
|
533.
|
The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy. [electronic resource] by
- Maruf, M
- Fascelli, M
- George, A K
- Siddiqui, M M
- Kongnyuy, M
- DiBianco, J M
- Muthigi, A
- Valayil, S
- Sidana, A
- Frye, T P
- Kilchevsky, A
- Choyke, P L
- Turkbey, B
- Wood, B J
- Pinto, P A
Producer: 20180222
In:
Prostate cancer and prostatic diseases vol. 20
Availability: No items available.
|
|
534.
|
Celastrol, an active constituent of the TCM plant Tripterygium wilfordii Hook.f., inhibits prostate cancer bone metastasis. [electronic resource] by
- Kuchta, K
- Xiang, Y
- Huang, S
- Tang, Y
- Peng, X
- Wang, X
- Zhu, Y
- Li, J
- Xu, J
- Lin, Z
- Pan, T
Producer: 20180222
In:
Prostate cancer and prostatic diseases vol. 20
Availability: No items available.
|
|
535.
|
Updated postoperative nomogram incorporating the number of positive lymph nodes to predict disease recurrence following radical prostatectomy. [electronic resource] by
- Nguyen, D P
- Kent, M
- Vilaseca, A
- Corradi, R B
- Fossati, N
- Sjoberg, D D
- Benfante, N
- Eastham, J A
- Scardino, P T
- Touijer, K A
Producer: 20180305
In:
Prostate cancer and prostatic diseases vol. 20
Availability: No items available.
|
|
536.
|
Celastrol, an active constituent of the TCM plant Tripterygium wilfordii Hook.f., inhibits prostate cancer bone metastasis. [electronic resource] by
- Kuchta, K
- Xiang, Y
- Huang, S
- Tang, Y
- Peng, X
- Wang, X
- Zhu, Y
- Li, J
- Xu, J
- Lin, Z
- Pan, T
Publication details: Prostate cancer and prostatic diseases 06 2017
In:
Prostate cancer and prostatic diseases vol. 20
Availability: No items available.
|
|
537.
|
Patient selection for prostate focal therapy in the era of active surveillance: an International Delphi Consensus Project. [electronic resource] by
- Tay, K J
- Scheltema, M J
- Ahmed, H U
- Barret, E
- Coleman, J A
- Dominguez-Escrig, J
- Ghai, S
- Huang, J
- Jones, J S
- Klotz, L H
- Robertson, C N
- Sanchez-Salas, R
- Scionti, S
- Sivaraman, A
- de la Rosette, J
- Polascik, T J
Producer: 20180515
In:
Prostate cancer and prostatic diseases vol. 20
Availability: No items available.
|
|
538.
|
|
|
539.
|
|
|
540.
|
|